Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
If you're a teacher who feels like you’re running on a treadmill that only goes faster, you aren't alone. Studies show that the typical teacher works a median of 54 hours per week. Yet, only 46% of ...
DNA Ginkgo Bioworks Holdings, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback